| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1399-0039.2011.01638.X |
| P698 | PubMed publication ID | 21299521 |
| P2093 | author name string | C Süsal | |
| C Morath | |||
| P2860 | cites work | Peri-operative immunoadsorption in sensitized renal transplant recipients. | Q44082728 |
| American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation | Q44495127 | ||
| Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients | Q44584357 | ||
| Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation | Q46077973 | ||
| Successful deceased-donor kidney transplantation in crossmatch-positive patients with peritransplant plasma exchange and Rituximab | Q46084219 | ||
| Almost all patients who are waiting for a regraft of a kidney transplant have anti-HLA antibodies | Q46126639 | ||
| Positive cross-match living donor kidney transplantation: longer-term outcomes | Q46134337 | ||
| Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience | Q46155740 | ||
| Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production | Q46270888 | ||
| Rituximab and intravenous immune globulin for desensitization during renal transplantation | Q46477840 | ||
| Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant? | Q46630985 | ||
| Dampening Ab responses using proteasome inhibitors following in vivo B cell activation | Q46769248 | ||
| Significance of the positive crossmatch test in kidney transplantation | Q47800073 | ||
| Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry. | Q52668051 | ||
| A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. | Q53639822 | ||
| Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. | Q55034268 | ||
| The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection | Q28299356 | ||
| Plasma exchange and immunoadsorption | Q33377027 | ||
| Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection | Q33382552 | ||
| Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial | Q34373536 | ||
| ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. | Q34382354 | ||
| Chronic allograft nephropathy: current concepts and future directions | Q34501818 | ||
| Presensitization: the problem and its management | Q34654726 | ||
| A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients | Q34991120 | ||
| Humoral theory of transplantation | Q35142603 | ||
| Infection in solid-organ transplant recipients | Q37038203 | ||
| Mechanisms of alloantibody production in sensitized renal allograft recipients | Q37473459 | ||
| Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols | Q37685188 | ||
| Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation | Q42872851 | ||
| An Integrative Approach for the Transplantation of High-Risk Sensitized Patients | Q42951982 | ||
| Effect of the proteasome inhibitor bortezomib on humoral immunity in two presensitized renal transplant candidates | Q43119566 | ||
| Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure | Q43918875 | ||
| Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report | Q43937861 | ||
| HLA antibodies and the occurrence of early adverse events in the modern era of transplantation: a collaborative transplant study report | Q43984184 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 177-186 | |
| P577 | publication date | 2011-03-01 | |
| P1433 | published in | Tissue Antigens | Q1573131 |
| P1476 | title | Current approaches to the management of highly sensitized kidney transplant patients | |
| P478 | volume | 77 |
| Q38703426 | Clinical Relevance of HLA Antibodies in Kidney Transplantation: Recent Data from the Heidelberg Transplant Center and the Collaborative Transplant Study |
| Q26998713 | Detection and clinical relevance of donor specific HLA antibodies: a matter of debate |
| Q46436844 | Intravenous human immunoglobulin treatment of serum from HLA-sensitized patients in kidney transplantation |
| Q51413561 | Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy. |
| Q37935058 | On the future of HLA. |
| Q35885244 | Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience. |
| Q45736192 | Plasmapheresis-resistant acute humoral rejection successfully treated with anti-C5 antibody |
| Q39033401 | Post-listing survival for highly sensitised patients on the UK kidney transplant waiting list: a matched cohort analysis |
| Q38010231 | Prevention of antibody-mediated kidney transplant rejection |
| Q26852927 | Resolve, revise, and relax: the 3 Rs of B cell repertoire adjustment |
| Q50950214 | The effectiveness of the combination of rituximab and high-dose immunoglobulin in the immunomodulation of sensitized kidney transplant candidates. |
| Q89416560 | Transplantation: Desensitization and survival in kidney transplant recipients |
Search more.